Label: ALLERGY RELIEF D- cetirizine hydrochloride, pseudoephedrine hydrochloride tablet, film coated, extended release
- NDC Code(s): 37808-651-53, 37808-651-62
- Packager: H E B
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated February 24, 2021
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients (in each extended release tablet)
- Purpose
-
Uses
- •
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- •
- runny nose
- •
- sneezing
- •
- itchy, watery eyes
- •
- itching of the nose or throat
- •
- nasal congestion
- •
- reduces swelling of nasal passages
- •
- temporarily relieves sinus congestion and pressure
- •
- temporarily restores freer breathing through the nose
-
Warnings
Do not use
- •
- if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
- •
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- heart disease
- •
- thyroid disease
- •
- diabetes
- •
- glaucoma
- •
- high blood pressure
- •
- trouble urinating due to an enlarged prostate gland
- •
- liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
- •
- do not use more than directed
- •
- drowsiness may occur
- •
- avoid alcoholic drinks
- •
- alcohol, sedatives, and tranquilizers may increase drowsiness
- •
- be careful when driving a motor vehicle or operating machinery
Stop use and ask a doctor if
- •
- an allergic reaction to this product occurs. Seek medical help right away.
- •
- you get nervous, dizzy, or sleepless
- •
- symptoms do not improve within 7 days or are accompanied by fever
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
Package/Label Principal Display Panel
Compare to Zyrtec-D® active ingredients
Allergy Relief-D
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Extended Release Tablets, 5 mg/120 mg
Antihistamine/Nasal Decongestant
Allergy & Congestion
12 Hour
Indoor & Outdoor Allergies
12 Hour Relief of:
Sneezing
Itchy, Watery Eyes
Runny Nose
Itchy Throat or Nose
Sinus Pressure
Nasal Congestion
actual size
12 EXTENDED RELEASE TABLETS
-
INGREDIENTS AND APPEARANCE
ALLERGY RELIEF D
cetirizine hydrochloride, pseudoephedrine hydrochloride tablet, film coated, extended releaseProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:37808-651 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE 5 mg PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 2165RE0K14) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color WHITE Score no score Shape ROUND Size 10mm Flavor Imprint Code L147 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:37808-651-53 12 in 1 CARTON 02/24/2021 1 1 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:37808-651-62 24 in 1 CARTON 02/18/2021 2 1 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA210719 02/18/2021 Labeler - H E B (007924756)